The Fort Worth Press - Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

USD -
AED 3.672497
AFN 65.999471
ALL 81.749912
AMD 377.657389
ANG 1.79008
AOA 916.489445
ARS 1447.774602
AUD 1.433949
AWG 1.80125
AZN 1.703098
BAM 1.656847
BBD 2.015105
BDT 122.260014
BGN 1.67937
BHD 0.377032
BIF 2953.091775
BMD 1
BND 1.272884
BOB 6.913553
BRL 5.239204
BSD 1.000479
BTN 90.561067
BWP 13.175651
BYN 2.857082
BYR 19600
BZD 2.012224
CAD 1.36841
CDF 2224.999659
CHF 0.778355
CLF 0.021805
CLP 860.999957
CNY 6.94215
CNH 6.94197
COP 3642
CRC 496.003592
CUC 1
CUP 26.5
CVE 93.41048
CZK 20.68075
DJF 178.163135
DKK 6.33486
DOP 63.049437
DZD 129.986956
EGP 46.961897
ERN 15
ETB 154.976835
EUR 0.84826
FJD 2.20805
FKP 0.729917
GBP 0.734446
GEL 2.689902
GGP 0.729917
GHS 10.985781
GIP 0.729917
GMD 73.500789
GNF 8780.996111
GTQ 7.67429
GYD 209.32114
HKD 7.80883
HNL 26.428662
HRK 6.385501
HTG 131.143652
HUF 321.991502
IDR 16828.55
ILS 3.10525
IMP 0.729917
INR 90.394901
IQD 1310.5
IRR 42125.000158
ISK 122.830055
JEP 0.729917
JMD 156.862745
JOD 0.708956
JPY 156.932007
KES 129.000202
KGS 87.450061
KHR 4029.999686
KMF 416.999794
KPW 899.945137
KRW 1467.869894
KWD 0.30742
KYD 0.83376
KZT 497.113352
LAK 21520.880015
LBP 86149.999963
LKR 309.665505
LRD 185.999907
LSL 16.060391
LTL 2.95274
LVL 0.60489
LYD 6.323093
MAD 9.174499
MDL 16.928505
MGA 4431.457248
MKD 52.289772
MMK 2099.936125
MNT 3569.846682
MOP 8.051354
MRU 39.72959
MUR 46.069927
MVR 15.459857
MWK 1737.999676
MXN 17.36485
MYR 3.947978
MZN 63.759773
NAD 16.060374
NGN 1371.399239
NIO 36.81834
NOK 9.708245
NPR 144.897432
NZD 1.670075
OMR 0.384506
PAB 1.000479
PEN 3.362498
PGK 4.286719
PHP 58.773502
PKR 279.84277
PLN 3.57756
PYG 6622.13506
QAR 3.64125
RON 4.321597
RSD 99.582996
RUB 76.249364
RWF 1459.958497
SAR 3.750129
SBD 8.064647
SCR 14.106828
SDG 601.502126
SEK 9.00598
SGD 1.27433
SHP 0.750259
SLE 24.549799
SLL 20969.499267
SOS 571.483593
SRD 37.894031
STD 20697.981008
STN 20.755852
SVC 8.7544
SYP 11059.574895
SZL 16.059778
THB 31.827019
TJS 9.349774
TMT 3.505
TND 2.845498
TOP 2.40776
TRY 43.532004
TTD 6.777163
TWD 31.677296
TZS 2584.99965
UAH 43.151654
UGX 3562.246121
UYU 38.562056
UZS 12264.970117
VES 377.98435
VND 25967.5
VUV 119.556789
WST 2.72617
XAF 555.589718
XAG 0.012686
XAU 0.000204
XCD 2.70255
XCG 1.803149
XDR 0.691101
XOF 555.690911
XPF 101.550041
YER 238.324995
ZAR 16.14345
ZMK 9001.198478
ZMW 19.585153
ZWL 321.999592
  • RYCEF

    -0.3100

    16.62

    -1.87%

  • RBGPF

    4.4200

    86.52

    +5.11%

  • VOD

    0.4600

    15.71

    +2.93%

  • RIO

    0.1100

    96.48

    +0.11%

  • CMSC

    -0.1400

    23.52

    -0.6%

  • GSK

    3.8900

    57.23

    +6.8%

  • NGG

    1.5600

    87.79

    +1.78%

  • AZN

    3.1300

    187.45

    +1.67%

  • SCS

    0.0200

    16.14

    +0.12%

  • BTI

    -0.2400

    61.63

    -0.39%

  • BP

    0.3800

    39.2

    +0.97%

  • RELX

    -0.7300

    29.78

    -2.45%

  • CMSD

    -0.0700

    23.87

    -0.29%

  • JRI

    0.0300

    13.15

    +0.23%

  • BCC

    5.3000

    90.23

    +5.87%

  • BCE

    0.2400

    26.34

    +0.91%

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.

Text size:

ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.

"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."

Solving the $1 million per study problem

While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.

This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.

Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.

The results are compelling:

  • Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.

  • $141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.

  • 51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.

Shaping the Future of Study Operations

Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.

Site Identification & Feasibility

Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.

Study Startup

AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.

Remote Monitoring

AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.

Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.

Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.

All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025

Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/

About Florence Healthcare

Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.

Contact Information

Seema Sheth-Voss
[email protected]
(888) 829-0896

SOURCE: Florence Healthcare



View the original press release on ACCESS Newswire

L.Davila--TFWP